Annual Total Liabilities
$6.37 M
-$867.90 K-11.99%
31 December 2023
Summary:
Cardiol Therapeutics annual total liabilities is currently $6.37 million, with the most recent change of -$867.90 thousand (-11.99%) on 31 December 2023. During the last 3 years, it has risen by +$4.32 million (+209.82%). CRDL annual total liabilities is now -30.18% below its all-time high of $9.13 million, reached on 31 December 2021.CRDL Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$5.25 M
-$2.75 M-34.38%
30 September 2024
Summary:
Cardiol Therapeutics quarterly total liabilities is currently $5.25 million, with the most recent change of -$2.75 million (-34.38%) on 30 September 2024. Over the past year, it has dropped by -$773.10 thousand (-12.84%). CRDL quarterly total liabilities is now -58.42% below its all-time high of $12.62 million, reached on 01 September 2018.CRDL Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRDL Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -12.0% | -12.8% |
3 y3 years | +209.8% | +152.9% |
5 y5 years | +260.1% | +318.8% |
CRDL Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -30.2% | +209.8% | -42.5% | +152.9% |
5 y | 5 years | -30.2% | +902.0% | -42.5% | +800.4% |
alltime | all time | -30.2% | +2084.7% | -58.4% | +1698.6% |
Cardiol Therapeutics Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $5.25 M(-34.4%) |
June 2024 | - | $8.00 M(-2.4%) |
Mar 2024 | - | $8.19 M(+28.5%) |
Dec 2023 | $6.37 M(-12.0%) | $6.37 M(+5.9%) |
Sept 2023 | - | $6.02 M(-5.3%) |
June 2023 | - | $6.35 M(+20.5%) |
Mar 2023 | - | $5.27 M(-27.2%) |
Dec 2022 | $7.24 M(-20.7%) | $7.24 M(+2.3%) |
Sept 2022 | - | $7.08 M(-20.1%) |
June 2022 | - | $8.86 M(+8.2%) |
Mar 2022 | - | $8.18 M(-10.3%) |
Dec 2021 | $9.13 M | - |
Dec 2021 | - | $9.13 M(+340.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $2.07 M(-14.6%) |
June 2021 | - | $2.43 M(+7.3%) |
Mar 2021 | - | $2.27 M(+10.1%) |
Dec 2020 | $2.06 M(+223.4%) | $2.06 M(+38.9%) |
Sept 2020 | - | $1.48 M(+53.9%) |
June 2020 | - | $962.20 K(+65.1%) |
Mar 2020 | - | $582.70 K(-8.4%) |
Dec 2019 | $636.00 K(-64.1%) | $636.00 K(-49.2%) |
Sept 2019 | - | $1.25 M(+73.1%) |
June 2019 | - | $723.70 K(-1.1%) |
Mar 2019 | - | $731.60 K(-58.7%) |
Dec 2018 | $1.77 M(+506.8%) | $1.77 M(-86.0%) |
Sept 2018 | - | $12.62 M(+4225.8%) |
Dec 2017 | $291.70 K | $291.70 K |
FAQ
- What is Cardiol Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Cardiol Therapeutics?
- What is Cardiol Therapeutics annual total liabilities year-on-year change?
- What is Cardiol Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cardiol Therapeutics?
- What is Cardiol Therapeutics quarterly total liabilities year-on-year change?
What is Cardiol Therapeutics annual total liabilities?
The current annual total liabilities of CRDL is $6.37 M
What is the all time high annual total liabilities for Cardiol Therapeutics?
Cardiol Therapeutics all-time high annual total liabilities is $9.13 M
What is Cardiol Therapeutics annual total liabilities year-on-year change?
Over the past year, CRDL annual total liabilities has changed by -$867.90 K (-11.99%)
What is Cardiol Therapeutics quarterly total liabilities?
The current quarterly total liabilities of CRDL is $5.25 M
What is the all time high quarterly total liabilities for Cardiol Therapeutics?
Cardiol Therapeutics all-time high quarterly total liabilities is $12.62 M
What is Cardiol Therapeutics quarterly total liabilities year-on-year change?
Over the past year, CRDL quarterly total liabilities has changed by -$773.10 K (-12.84%)